EL ESTEE LAUDER COMPANIES INC
Perfumes, Cosmetics & Other Toilet Preparations · NYSE · SEC CIK 1001250 · Fiscal year ends 06/30
Financial factors as of 2026-09-30 (2027Q1), TTM = sum of the last four quarters
Growth
TTM revenue YoY5.8%
TTM net income YoY139.6%
TTM EPS YoY139.0%
Revenue 3-yr CAGR-0.5%
Net income 3-yr CAGR-12.9%
Margins
Gross margin76.0%
Operating margin6.7%
Net margin2.4%
FCF margin9.9%
EBITDA margin11.8%
Returns
ROE9.3%
ROA1.9%
ROIC (approx.)6.1%
Asset turnover0.78x
Leverage & solvency
Liabilities / assets79.8%
Debt / equity1.67x
Current ratio1.25x
Interest coverage3.08x
Cash quality & payout
Operating cash flow / net income5.29x
Accruals ratio-8.0%
Payout ratio137.8%
Capex / revenue2.8%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY2026*2026-06-30 | FY2025*2025-06-30 |
|---|---|---|
| Income statement | ||
| Revenue | $15.05B | $14.33B |
| Cost of revenue | $3.69B | $3.73B |
| Gross profit | $11.36B | $10.60B |
| SG&A expense | $9.69B | $9.46B |
| Operating income | $780.00M | -$785.00M |
| Interest expense | $334.00M | $357.00M |
| Pretax income | $517.00M | -$1.04B |
| Income tax | $335.00M | $93.00M |
| Net income | $182.00M | -$1.13B |
| EBITDA | $1.58B | $44.00M |
| EPS (basic) | 0.50 | -3.15 |
| EPS (diluted) | 0.50 | -3.15 |
| Dividends declared per share | 1.40 | 1.71 |
| Weighted avg. shares (diluted) | 364.80M | 360.10M |
| Balance sheet | ||
| Cash & equivalents | $3.50B | $2.92B |
| Receivables | $1.52B | $1.53B |
| Inventory | $2.00B | $2.07B |
| Current assets | $7.61B | $7.07B |
| PP&E, net | $2.81B | $3.17B |
| Goodwill | $2.11B | $2.13B |
| Intangibles | $3.58B | $3.76B |
| Total assets | $19.76B | $19.89B |
| Current liabilities | $6.23B | $5.43B |
| Short-term debt | $503.00M | $3.00M |
| Long-term debt | $6.80B | $7.31B |
| Total debt | $7.31B | $7.32B |
| Total liabilities | $15.96B | $16.03B |
| Shareholders' equity | $3.81B | $3.87B |
| Net debt | $3.81B | $4.40B |
| Cash flow statement | ||
| Operating cash flow | $1.77B | $1.27B |
| Capital expenditure | $457.00M | $602.00M |
| Free cash flow | $1.32B | $670.00M |
| Investing cash flow | -$489.00M | -$623.00M |
| Financing cash flow | -$712.00M | -$1.14B |
| Depreciation & amortization | $796.00M | $829.00M |
| Stock-based compensation | $310.00M | $304.00M |
| Dividends paid | $508.00M | $618.00M |
| Share buybacks | $70.00M | $35.00M |
Free plan shows the latest 2 periods; Pro shows all 18 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.